Table 2 Representative unique metabolites to mouse and human BALF and plasma.

From: Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice

Compound

Biofluid

Type

Formula

Accession ID

3-keto Fusidic acid

Human BALF

Drug (fusidic acid) metabolite

C31 H46 O7

HMDB60745

Epi-coprostanol

Human BALF

Endogenous

C27 H48 O

HMDB01569

N-Formyl-L-methionine

Human BALF

Endogenous

C6 H11 N O3 S

HMDB01015

N-hexadecanoyl-leucine

Human BALF

Endogenous

C22 H43 N O3

LMFA08020115

P1,P4-Bis(5′-xanthosyl) tetraphosphate

Human BALF

Endogenous

C20 H26 N8 O23 P4

HMDB03834

PE(35:0)

Human BALF

Odd chain lipid

C40 H80 N O8 P

HMDB08899

Sphingosine-1-phosphate (d19:1-P)

Human BALF

Odd chain lipid

C19 H42 N O5 P

HMDB60062

Uridine diphosphate acetylgalactosamine 4-sulfate

Human BALF

Endogenous

C17 H27 N3 O20 P2 S

HMDB00934

8-Hydroxycarteolol

Human Plasma

Drug (carteolol) metabolite

C16 H24 N2 O4

HMDB60990

DG(29:1)

Human Plasma

Odd chain lipid

C32 H60 O5

HMDB55987

DG(33:4)

Human Plasma

Odd chain lipid

C36 H62 O5

HMDB07329

Hydroxybupropion

Human Plasma

Endogenous

C13 H18 Cl N O2

HMDB12235

N-hexadecanoyl-glutamic acid

Human Plasma

Endogenous

C21 H39 N O5

LMFA08020087

Piperine

Human Plasma

Food

C17 H19 N O3

HMDB29377

Stearoylethanolamide

Human Plasma

Endogenous

C20 H41 N O2

HMDB13078

Valeracetate

Human Plasma

Food

C17 H28 O3

HMDB41388

N-hexadecanoyl-valine

Mouse BALF

Endogenous

C21 H41 N O3

LMFA08020120

Urocanic acid

Mouse BALF

Endogenous

C6 H6 N2 O2

HMDB00301

Endomorphin-1

Mouse Plasma

Endogenous

C34 H38 N6 O5

HMDB05773

N-Nonanoylglycine

Mouse Plasma

Endogenous

C11 H21 N O3

HMDB13279

PIP(38:3)

Mouse Plasma

Endogenous

C47 H86 O16 P2

HMDB09989

Pristanal

Mouse Plasma

Endogenous

C19 H38 O

HMDB01958

PE(39:1)

Mouse Plasma

Odd chain lipid

C44 H86 N O8 P

HMDB09747

PS(37:5)

Mouse Plasma

Odd chain lipid

C43 H74 N O10 P

LMGP03010599

  1. This list contains randomly selected metabolites that were annotated using an in-house database comprised of METLIN, HMDB, Lipid Maps and KEGG. Metabolites were selected randomly. Scores ≥70 out of a possible 100 and mass errors ≤10 ppm were used for annotation thresholds. Annotations were based on exact mass and isotope ratios. DG: diglyceride, PE: phosphatidylethanolamine, PIP: phosphatidylinositol phosphate, PS: phosphatidylserine.